Abdera President and CEO Lori Lyons-Williams will attend the inaugural Guggenheim Healthcare Conference in Boston, MA to participate in a panel discussion. We look forward to hearing more of her expertise and insight.
Abdera Therapeutics
Biotechnology Research
South San Francisco, California 12,253 followers
About us
Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options. Abdera Therapeutics is growing rapidly and seeking key new team members who thrive at the cutting-edge of innovation. Come join us and be a part of the ground-breaking team set to unlock the power of targeted radiotherapy!
- Website
-
http://www.abderatx.com
External link for Abdera Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
Locations
-
Primary
901 Gateway Blvd
South San Francisco, California 94080, US
-
Vancouver, British Columbia, CA
Employees at Abdera Therapeutics
Updates
-
This November, we observe #LungCancerAwarenessMonth to highlight the importance of lung health and raise awareness about the risks, early detection, and more. As the leading cause of cancer deaths globally, lung cancer impacts countless lives. Together, we share the responsibility of working toward a future where #lungcancer no longer claims so many lives.
-
When it comes to embodying Abdera's values, Brandon Kwan and Lily Lee are incredible examples of how they incorporate them every day. These individuals go above and beyond by demonstrating courage in their decisions, ownership in their actions, communicating openly, and working together to achieve our goals. It's team players like them who make our workplace shine, and we couldn't be happier to have them on #TeamAbdera!
-
Whether in San Francisco or Vancouver, #TeamAbdera had high spirits dressing up for #Halloween today. We had a great time seeing everyone’s creativity and personality shine through in their costumes. Check out some highlights from today’s costume contest!
-
Wishing a happy #Thanksgiving day to all our colleagues, family, and friends in Canada! The Abdera team sends warm greetings as we all take time to enjoy the beauty of autumn and the spirit of togetherness this holiday brings.
-
Cancer affects countless lives each year, and at Abdera, we are committed to driving change and helping build a future free of it. We're honored to have been sponsors of the American Cancer Society's 13th Annual San Francisco Discovery Gala. We were inspired by the evening's shared hope and dedication to supporting #ACS in their mission to fight #cancer.
-
Our team had a great time attending the Fierce Biotech #Fierce15 Award Ceremony in Boston this week, celebrating and connecting with the top innovators in #biotech. We are grateful for our team’s dedication, which has allowed us to continue pushing boundaries and making strides in transforming treatment options. Congratulations to all of this year’s honorees!
-
Another successful 5K for #TeamAbdera! Some of our SSF team members joined the GO2 for Lung Cancer Foundation’s 5K, seizing the chance to get moving for a cause close to our hearts. “It was a great, energetic, and friendly crowd, full of people supporting those who have been impacted by lung cancer,” shares Carly Loeb, PhD.
-
Our very own, co-founder and chief operating officer, Lana Janes, Ph.D., recently took the stage to represent Abdera during a panel discussion about the biologic revolution in #radiotherapies at the 2024 World Medical Innovation Forum in Boston. We’re proud to have been part of this important conversation shaping the future of #cancer care. #WMIF2024
-
We’re proud to share that Executive Director, Biologics, Emma Cummins, has been selected to join the prestigious adMare BioInnovations Academy Executive Institute. This highly selective program admits only 20 participants each year and stands at the forefront of leadership cultivation. It’s designed to foster growth and learning in the industry. We look forward to all that you will achieve, Emma!